Educational Programs Based on Healthy Habits to Improve Quality of Life and Psychosocial Profile in Women With Neurodegenerative Diseases: the ADVICE Protocol Study (Phase 2)
ADVICE Phase 2
2 other identifiers
interventional
60
1 country
1
Brief Summary
This phase of the project aims to compare in-person, supervised educational programs (EP) with online self-guided EPs in individuals with relapsing-remitting multiple sclerosis. A total of 75 participants will be randomly assigned to one of three groups: a supervised and individualized educational program focused on HIIT training, a supervised and individualized educational program focused on strength training, and a non-supervised, self-guided educational program based on resistance band training. Additionally, sessions on the Mediterranean diet (both supervised and non-supervised) and cognitive-behavioral interventions will be included. A control evaluation will be conducted three months after the intervention to assess the effects of the educational programs, followed by another evaluation three months later to analyze residual effects. Women who participated in Phase 1 of the study will be invited to take part in this second phase.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 20, 2025
CompletedFirst Posted
Study publicly available on registry
March 19, 2025
CompletedStudy Start
First participant enrolled
April 15, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 28, 2026
ExpectedMarch 24, 2026
March 1, 2026
2 months
February 20, 2025
March 22, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Satisfaction with Physical Activity
Satisfaction with Physical Activity will be measured using an eight-item, 5-point Likert scale
Baseline (pre-intervention)
Satisfaction with Physical Activity
Satisfaction with Physical Activity will be measured using an eight-item, 5-point Likert scale
Immediately after the intervention
Visual Analogue Scale for Fatigue (VAS-F)
The Visual Analogue Scale for Fatigue (VAS-F) assesses subjective levels of fatigue and energy
Immediately before each of the 36 exercise sessions (pre-session assessment).
Visual Analogue Scale for Fatigue (VAS-F)
The Visual Analogue Scale for Fatigue (VAS-F) assesses subjective levels of fatigue and energy
Immediately after each of the 36 exercise sessions (post-session assessment).
Modified Fatigue Impact Scale (MFIS)
Fatigue perception will be measured using the MFIS. This scale is a 21-item multidimensional questionnaire that evaluates the physical, cognitive, and psychosocial effects of fatigue on a five-point ordinal scale (with a maximum total score of 84).
Baseline (pre-intervention).
Modified Fatigue Impact Scale (MFIS)
Fatigue perception will be measured using the MFIS. This scale is a 21-item multidimensional questionnaire that evaluates the physical, cognitive, and psychosocial effects of fatigue on a five-point ordinal scale (with a maximum total score of 84)
48 hours after the last exercise session (post-intervention assessment).
Secondary Outcomes (61)
Inflammatory Profile
Baseline (pre-intervention).
Inflammatory Profile
48 hours after the last exercise session (post-intervention assessment).
The hormonal profile
Pre-intervention in each phase of the menstrual cycle (early follicular phase, late follicular phase and mid-luteal phase).
Cognitive Function
Baseline (pre-intervention).
Cognitive Function
48 hours after the last exercise session (post-intervention assessment).
- +56 more secondary outcomes
Study Arms (2)
Supervised Strength Training Program (PE1)
EXPERIMENTALParticipants will complete 36 strength sessions (3 times a week) at a moderate intensity, 6 educational nutritional intervention sessions, and 8 sessions on energy and fatigue management.
Self-Guided and Unsupervised Program with General Recommendations (PE1)
ACTIVE COMPARATORParticipants will be involved in an unsupervised, self-directed program focusing on physical exercise (three times per week), nutrition and cognitive-behavioral habits.
Interventions
This arm of the study consists of a supervised strength training program, conducted over 12 weeks with three weekly sessions. The sessions follow a wave-like periodization, with intensities ranging from 70% to 85% of 1-RM. Exercises focus on enhancing neuromuscular strength in the lower limbs, such as leg presses and hip extensions, under the supervision of a multidisciplinary team. Participants will also receive nutritional guidance based on the Mediterranean diet, as well as cognitive-behavioral therapy strategies aimed at optimizing fatigue management and boosting energy levels.
This arm of the study consists of a self-guided and unsupervised program based on physical exercise (3 times per week), nutrition, and cognitive-behavioral habits. Participants will access online modules that provide guidelines for performing resistance exercises with bands, dietary recommendations following the principles of the Mediterranean diet, and cognitive-behavioral techniques for fatigue management.
Eligibility Criteria
You may qualify if:
- Women and men of reproductive age (18-45 years) with MS will be included, with the upper age limit adjusted to reflect the reproductive phase;
- no iron-deficiency anemia;
- stable disease phase;
- independent walking ability for over 10 meters.
- Women will be recruited first and later matched with men based on age, EDSS, and lifestyle habits (physical activity, smoking, and alcohol consumption).
You may not qualify if:
- score \<1 or \>6 on the EDSS;
- report a relapse within 12 months before the study begins;
- have taken corticosteroid treatment within the last 2 months;
- have participated in a structured training program in the previous 6 months.
- Once all women with MS are recruited, male participants will be recruited following a 1:1 matching methodology based on age, geographic region, and lifestyle habits.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital Universitario Virgen de la Arrixaca
Murcia, Murcia, 30120, Spain
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 20, 2025
First Posted
March 19, 2025
Study Start
April 15, 2025
Primary Completion
June 15, 2025
Study Completion (Estimated)
July 28, 2026
Last Updated
March 24, 2026
Record last verified: 2026-03